Literature DB >> 23529331

The dedifferentiation of neuroendocrine tumor metastases: myth or reality?

Cătălina Poiană1, M C Neamţu, Elena Taina Avramescu, Mara Carşote, Raluca Trifănescu, Dana Terzea, Oana Maria Neamţu, Rucsandra Dănciulescu Miulescu.   

Abstract

Dedifferentiation is a process that may be found in metastasis from the neuroendocrine tumors. We present the case of a female within the seventh decade of life incidentally diagnosed with a mature teratoma with element of cartilages, bronchia, mucinous glands, and a poorly differentiated neuroendocrine carcinoma (Ki67 of 30%). After six months of chemotherapy and another six months of disease free interval, a metastasis of the great omentum was removed. The dedifferentiation was diagnosed based on much higher Ki67 (of 70%). The loss of estrogen receptor of 40% from the initial site to 3% into metastasis indicates an exclusive neuroendocrine aggressive pattern. The ovarian carcinoid is a rare situation, and metastasis to the great omentum with dedifferentiation is even seldom.

Entities:  

Mesh:

Year:  2013        PMID: 23529331

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  2 in total

Review 1.  Liver transplantation for metastatic neuroendocrine tumors.

Authors:  Louise Barbier; Cindy Neuzillet; Safi Dokmak; Alain Sauvanet; Philippe Ruszniewski; Jacques Belghiti
Journal:  Hepat Oncol       Date:  2014-12-11

2.  Somatostatin receptors in normal and acromegalic somatotroph cells: the U-turn of the clinician to immunohistochemistry report - a review.

Authors:  Nina Ionovici; Mara Carsote; Dana Cristina Terzea; Anca Mihaela Predescu; Anne Marie Rauten; Mihaela Popescu
Journal:  Rom J Morphol Embryol       Date:  2020 Apr-Jun       Impact factor: 1.033

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.